Trial Profile
YM1170 Phase 2/3 Study: A Double Blind, Placebo Controlled, Group-Comparison Study in Patients With Non-Erosive Gastroesophageal Reflux Disease.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 30 Nov 2011
Price :
$35
*
At a glance
- Drugs Famotidine (Primary)
- Indications Gastro-oesophageal reflux; Heartburn
- Focus Therapeutic Use
- 22 Oct 2007 Status changed from in progress to completed.
- 28 Sep 2006 Status change
- 05 Nov 2005 New trial record.